Skip to main content
Addgene

pMP71-hCD155
(Plasmid #118630)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 118630 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pMP71
  • Backbone size w/o insert (bp) 5500
  • Total vector size (bp) 6895
  • Modifications to backbone
    Gateway compatible (see Wälchli et al. 2011, PlosONE)
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    CD155
  • Alt name
    Nectin-like protein 5
  • Alt name
    Poliovirus receptor
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    1254
  • GenBank ID
    NM_006505.3
  • Entrez Gene
    PVR (a.k.a. CD155, HVED, NECL5, Necl-5, PVS, TAGE4)
  • Promoter LTR

Cloning Information

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Cloned from pCMV3-C-HA-CD155 a commercial construct from Sino Biological (# HG10109-CY)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

The HA tag was removed to create an untagged ORF

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMP71-hCD155 was a gift from Sébastien Walchli (Addgene plasmid # 118630 ; http://n2t.net/addgene:118630 ; RRID:Addgene_118630)

  • For your References section:

    TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma. Josefsson SE, Beiske K, Blaker YN, Forsund MS, Holte H, Ostenstad B, Kimby E, Koksal H, Walchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH. Cancer Immunol Res. 2019 Mar;7(3):355-362. doi: 10.1158/2326-6066.CIR-18-0351. Epub 2019 Jan 18. 10.1158/2326-6066.CIR-18-0351 PubMed 30659053
Related items:
Commonly requested with: